Does IMATINIB Cause Chronic graft versus host disease? 161 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 161 reports of Chronic graft versus host disease have been filed in association with IMATINIB (Imatinib). This represents 0.4% of all adverse event reports for IMATINIB.
161
Reports of Chronic graft versus host disease with IMATINIB
0.4%
of all IMATINIB reports
29
Deaths
27
Hospitalizations
How Dangerous Is Chronic graft versus host disease From IMATINIB?
Of the 161 reports, 29 (18.0%) resulted in death, 27 (16.8%) required hospitalization, and 3 (1.9%) were considered life-threatening.
Is Chronic graft versus host disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMATINIB. However, 161 reports have been filed with the FAERS database.
What Other Side Effects Does IMATINIB Cause?
Death (9,708)
Drug ineffective (2,628)
Nausea (2,379)
Diarrhoea (2,203)
Fatigue (1,810)
Malignant neoplasm progression (1,716)
Vomiting (1,599)
Malaise (1,361)
Drug intolerance (1,354)
Drug resistance (1,293)
What Other Drugs Cause Chronic graft versus host disease?
CYCLOSPORINE (1,012)
MYCOPHENOLATE MOFETIL (848)
METHOTREXATE (708)
TACROLIMUS (659)
CYCLOPHOSPHAMIDE (531)
FLUDARABINE (420)
RUXOLITINIB (321)
BUSULFAN (309)
PREDNISONE (251)
RITUXIMAB (244)
Which IMATINIB Alternatives Have Lower Chronic graft versus host disease Risk?
IMATINIB vs IMBRUVICA
IMATINIB vs IMDEVIMAB
IMATINIB vs IMEGLIMIN
IMATINIB vs IMETELSTAT
IMATINIB vs IMIDAPRIL